Kirkland, WA, United States of America

Carlos Gaitán

This inventor holds 1 USPTO granted patent. Top assignee: Pathai, Inc.. Active years: 2026.


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Carlos Gaitán: Innovator in Predictive Healthcare Technology

Introduction

Carlos Gaitán is an accomplished inventor based in Kirkland, WA (US). He has made significant contributions to the field of healthcare technology, particularly in the area of predictive modeling for disease severity.

Latest Patents

Carlos Gaitán holds a patent for "Systems and methods for predicting disease severity in ulcerative colitis." This innovative patent describes a method, system, or non-transitory computer-readable storage medium for training models to predict ulcerative colitis (UC) severity based on human-interpretable image features extracted from whole-slide images. The process involves accessing a plurality of annotated whole-slide images associated with UC patients, extracting human-interpretable image features, training a statistical model, and storing the trained model on a storage device. He has 1 patent to his name.

Career Highlights

Carlos Gaitán is currently employed at Pathai, Inc., where he continues to develop cutting-edge technologies aimed at improving healthcare outcomes. His work focuses on leveraging advanced imaging techniques and machine learning to enhance the understanding and treatment of ulcerative colitis.

Collaborations

Carlos collaborates with talented professionals in his field, including Fedaa Najdawi and Kathleen Sucipto. Their combined expertise contributes to the innovative projects at Pathai, Inc.

Conclusion

Carlos Gaitán is a notable inventor whose work in predictive healthcare technology is paving the way for advancements in the treatment of ulcerative colitis. His contributions are essential in the ongoing effort to improve patient care and outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…